Chapter/Section Purchase

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biomarker Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Consumables
1.2.3 Service
1.3 Market by Application
1.3.1 Global Biomarker Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Diagnostics Development
1.3.3 Drug Discovery and Development
1.3.4 Disease-Risk
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Biomarker Market Perspective (2017-2028)
2.2 Biomarker Growth Trends by Region
2.2.1 Biomarker Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Biomarker Historic Market Size by Region (2017-2022)
2.2.3 Biomarker Forecasted Market Size by Region (2023-2028)
2.3 Biomarker Market Dynamics
2.3.1 Biomarker Industry Trends
2.3.2 Biomarker Market Drivers
2.3.3 Biomarker Market Challenges
2.3.4 Biomarker Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biomarker Players by Revenue
3.1.1 Global Top Biomarker Players by Revenue (2017-2022)
3.1.2 Global Biomarker Revenue Market Share by Players (2017-2022)
3.2 Global Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biomarker Revenue
3.4 Global Biomarker Market Concentration Ratio
3.4.1 Global Biomarker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biomarker Revenue in 2021
3.5 Biomarker Key Players Head office and Area Served
3.6 Key Players Biomarker Product Solution and Service
3.7 Date of Enter into Biomarker Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biomarker Breakdown Data by Type
4.1 Global Biomarker Historic Market Size by Type (2017-2022)
4.2 Global Biomarker Forecasted Market Size by Type (2023-2028)
5 Biomarker Breakdown Data by Application
5.1 Global Biomarker Historic Market Size by Application (2017-2022)
5.2 Global Biomarker Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Biomarker Market Size (2017-2028)
6.2 North America Biomarker Market Size by Type
6.2.1 North America Biomarker Market Size by Type (2017-2022)
6.2.2 North America Biomarker Market Size by Type (2023-2028)
6.2.3 North America Biomarker Market Share by Type (2017-2028)
6.3 North America Biomarker Market Size by Application
6.3.1 North America Biomarker Market Size by Application (2017-2022)
6.3.2 North America Biomarker Market Size by Application (2023-2028)
6.3.3 North America Biomarker Market Share by Application (2017-2028)
6.4 North America Biomarker Market Size by Country
6.4.1 North America Biomarker Market Size by Country (2017-2022)
6.4.2 North America Biomarker Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Biomarker Market Size (2017-2028)
7.2 Europe Biomarker Market Size by Type
7.2.1 Europe Biomarker Market Size by Type (2017-2022)
7.2.2 Europe Biomarker Market Size by Type (2023-2028)
7.2.3 Europe Biomarker Market Share by Type (2017-2028)
7.3 Europe Biomarker Market Size by Application
7.3.1 Europe Biomarker Market Size by Application (2017-2022)
7.3.2 Europe Biomarker Market Size by Application (2023-2028)
7.3.3 Europe Biomarker Market Share by Application (2017-2028)
7.4 Europe Biomarker Market Size by Country
7.4.1 Europe Biomarker Market Size by Country (2017-2022)
7.4.2 Europe Biomarker Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biomarker Market Size (2017-2028)
8.2 Asia-Pacific Biomarker Market Size by Type
8.2.1 Asia-Pacific Biomarker Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Biomarker Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Biomarker Market Share by Type (2017-2028)
8.3 Asia-Pacific Biomarker Market Size by Application
8.3.1 Asia-Pacific Biomarker Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Biomarker Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Biomarker Market Share by Application (2017-2028)
8.4 Asia-Pacific Biomarker Market Size by Region
8.4.1 Asia-Pacific Biomarker Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Biomarker Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Biomarker Market Size (2017-2028)
9.2 Latin America Biomarker Market Size by Type
9.2.1 Latin America Biomarker Market Size by Type (2017-2022)
9.2.2 Latin America Biomarker Market Size by Type (2023-2028)
9.2.3 Latin America Biomarker Market Share by Type (2017-2028)
9.3 Latin America Biomarker Market Size by Application
9.3.1 Latin America Biomarker Market Size by Application (2017-2022)
9.3.2 Latin America Biomarker Market Size by Application (2023-2028)
9.3.3 Latin America Biomarker Market Share by Application (2017-2028)
9.4 Latin America Biomarker Market Size by Country
9.4.1 Latin America Biomarker Market Size by Country (2017-2022)
9.4.2 Latin America Biomarker Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biomarker Market Size (2017-2028)
10.2 Middle East & Africa Biomarker Market Size by Type
10.2.1 Middle East & Africa Biomarker Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Biomarker Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Biomarker Market Share by Type (2017-2028)
10.3 Middle East & Africa Biomarker Market Size by Application
10.3.1 Middle East & Africa Biomarker Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Biomarker Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Biomarker Market Share by Application (2017-2028)
10.4 Middle East & Africa Biomarker Market Size by Country
10.4.1 Middle East & Africa Biomarker Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Biomarker Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 QIAGEN N.V. (Netherlands)
11.1.1 QIAGEN N.V. (Netherlands) Company Details
11.1.2 QIAGEN N.V. (Netherlands) Business Overview
11.1.3 QIAGEN N.V. (Netherlands) Biomarker Introduction
11.1.4 QIAGEN N.V. (Netherlands) Revenue in Biomarker Business (2017-2022)
11.1.5 QIAGEN N.V. (Netherlands) Recent Developments
11.2 PerkinElmer, Inc. (U.S.)
11.2.1 PerkinElmer, Inc. (U.S.) Company Details
11.2.2 PerkinElmer, Inc. (U.S.) Business Overview
11.2.3 PerkinElmer, Inc. (U.S.) Biomarker Introduction
11.2.4 PerkinElmer, Inc. (U.S.) Revenue in Biomarker Business (2017-2022)
11.2.5 PerkinElmer, Inc. (U.S.) Recent Developments
11.3 Merck Millipore (U.S.)
11.3.1 Merck Millipore (U.S.) Company Details
11.3.2 Merck Millipore (U.S.) Business Overview
11.3.3 Merck Millipore (U.S.) Biomarker Introduction
11.3.4 Merck Millipore (U.S.) Revenue in Biomarker Business (2017-2022)
11.3.5 Merck Millipore (U.S.) Recent Developments
11.4 Bio-Rad Laboratories, Inc. (U.S.)
11.4.1 Bio-Rad Laboratories, Inc. (U.S.) Company Details
11.4.2 Bio-Rad Laboratories, Inc. (U.S.) Business Overview
11.4.3 Bio-Rad Laboratories, Inc. (U.S.) Biomarker Introduction
11.4.4 Bio-Rad Laboratories, Inc. (U.S.) Revenue in Biomarker Business (2017-2022)
11.4.5 Bio-Rad Laboratories, Inc. (U.S.) Recent Developments
11.5 Enzo Biochem, Inc. (U.S.)
11.5.1 Enzo Biochem, Inc. (U.S.) Company Details
11.5.2 Enzo Biochem, Inc. (U.S.) Business Overview
11.5.3 Enzo Biochem, Inc. (U.S.) Biomarker Introduction
11.5.4 Enzo Biochem, Inc. (U.S.) Revenue in Biomarker Business (2017-2022)
11.5.5 Enzo Biochem, Inc. (U.S.) Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer